CHEST 2021

Sleep apnea research presented at CHEST 2021 examined links between PAP therapy adherence and the prevalence and severity of excessive daytime sleepiness.

Is long-term oxygen therapy needed by most patients after hospitalization for COVID-19?

Pooled data from the LEAP 1 and 2 trials were used to study the efficacy and safety of lefamulin in patients with CABP at risk for severe pneumonia.

An analysis of the CHRONICLE study of severe, uncontrolled asthma showed biologics decreased exacerbations in patient subgroups not previously included in RCTs.

Is there a clinical correlation between patient outcomes for COVID-19 and the use and dosage of acetaminophen?

Is asthma triple therapy with umeclidinium plus fluticasone furoate/vilanterol effective for patients with uncontrolled asthma who overuse SABA as rescue therapy?

Which therapy more effectively reduces severe COPD exacerbations: once-daily FF/UMEC/VI or twice-daily ICS/LABA?

To what extent does hospital fluid culture influence the mortality rates of patients with severe sepsis and septic shock?

To address the void in data on ventilation trends among children with asthma, investigators analyzed data from the largest US all-payer database.

Research presented at CHEST 2021 assessed an alternative approach to predicting COPD exacerbations during the COVID-19 pandemic.